JBK Associates in the News

Marizyme, Inc. Appoints Veteran Business Executive Julie Kampf to Board

JUPITER, Fla., Feb. 4, 2021 /PRNewswire/ -- Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has named veteran business executive Julie Kampf as an Independent Member of its Board of Directors.

By |2023-05-11T14:58:22-04:00May 11, 2023|Comments Off on news

Share This Story, Choose Your Platform!

About the Author:

Go to Top